Backstrom Jay T.
Insider CIK 1796398 · XLRN EVP, Research and Development · AGIO Director · SRRK CHIEF EXECUTIVE OFFICER, Director · IRON Director · LVTX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2026-07-08 | 2026-07-10 | 1,447 | — | $0 | 2,894 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award | 2026-07-08 | 2026-07-10 | 1,447 | — | $0 | 1,447 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2026-06-18 | 2026-06-23 | 2,927 | — | $0 | 2,927 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2026-06-18 | 2026-06-23 | 14,950 | — | $0 | 14,950 | SEC↗ |
| LVTX LAVA Therapeutics NV | D To issuer deriv | 2025-11-13 | 2025-11-17 | 33,390 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2025-07-08 | 2025-07-10 | 4,341 | — | $0 | 4,341 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2025-07-08 | 2025-07-10 | 23,393 | — | $0 | 23,393 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award deriv | 2025-03-10 | 2025-03-12 | 151,430 | — | $0 | 151,430 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award | 2025-03-10 | 2025-03-12 | 113,570 | — | $0 | 425,561 | SEC↗ |
| SRRK Scholar Rock Holding Corp | S Sale | 2025-02-18 | 2025-02-20 | 18,372 | $36.83 | $676.6K | 311,991 | SEC↗ |
| LVTX LAVA Therapeutics NV | A Award deriv | 2025-02-13 | 2025-02-18 | 33,390 | — | $0 | 33,390 | SEC↗ |
| SRRK Scholar Rock Holding Corp | S Sale | 2025-01-16 | 2025-01-21 | 22,308 | $44.20 | $986.0K | 330,363 | SEC↗ |
| SRRK Scholar Rock Holding Corp | S Sale | 2024-02-16 | 2024-02-20 | 11,614 | $15.74 | $182.8K | 352,671 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award deriv | 2024-02-12 | 2024-02-13 | 285,715 | — | $0 | 285,715 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award | 2024-02-12 | 2024-02-13 | 214,285 | — | $0 | 364,285 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award deriv | 2023-02-13 | 2023-02-15 | 200,000 | — | $0 | 200,000 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award | 2023-02-13 | 2023-02-15 | 150,000 | — | $0 | 150,000 | SEC↗ |
| IRON Disc Medicine, Inc. | A Award deriv | 2022-12-29 | 2023-01-03 | 7,000 | — | $0 | 7,000 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award deriv | 2022-09-20 | 2022-09-22 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 20,896 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 96,963 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | U Tender | 2021-11-19 | 2021-11-22 | 21,233 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2021-01-29 | 2021-02-02 | 20,896 | — | $0 | 20,896 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2021-01-29 | 2021-02-02 | 5,409 | — | $0 | 20,781 | SEC↗ |
| XLRN ACCELERON PHARMA INC | F Tax w/h | 2021-01-04 | 2021-01-06 | 1,735 | $124.31 | $215.7K | 15,372 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2020-01-02 | 2020-01-03 | 94,865 | — | $0 | 94,865 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2020-01-02 | 2020-02-10 | 96,963 | — | $0 | 96,963 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2020-01-02 | 2020-01-03 | 17,107 | — | $0 | 17,107 | SEC↗ |